Edmund Lowrie - Academia.edu (original) (raw)
Uploads
Papers by Edmund Lowrie
These guidelines are based on the best information available at the time of publication. They are... more These guidelines are based on the best information available at the time of publication. They are designed to provide information and assist in decision making. They are not intended to define a standard of care, and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of these guidelines is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. K/DOQI is a trademark of the National Kidney Foundation. FOREWORD F ROM ITS RUDIMENTARY beginnings in the 1960s, renal replacement therapy has become a lifesaving treatment that can provide end-stage renal disease (ESRD) patients with a good quality of life. As a resu...
Reprocessing dialysers for multiple uses: recent analysis of death risks for patients
Computers and Biomedical Research, 1976
ABSTRACT
California Medicine, 1968
These discussions are selected from the weekly staff conferences in the Department of Medicine, U... more These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California Medical Center, San Francisco. Taken from transcriptions, they are prepared by Drs. Martin J. Cline and Hibbard E. Williams, Associate Professors of Medicine, under the direction of Dr. Lloyd H. Smith, Jr., Professor of Medicine and Chairman of the Department of Medicine.
Computers and Biomedical Research, 1976
ABSTRACT
Nephrology Dialysis Transplantation
Kidney International, 2009
N Engl J Med, 1981
This report summarizes morbidity in 151 patients in a cooperative trial designed to evaluate the ... more This report summarizes morbidity in 151 patients in a cooperative trial designed to evaluate the clinical effects of different dialysis prescriptions. Four treatment groups were divided along two dimensions: dialysis treatment time (long or short), and blood urea nitrogen (BUN) concentration averaged with respect to time (TACurea) (high or low). Dietary protein was not restricted. There was no difference in mortality between the groups. Withdrawal of patients from the high-BUN groups for medical reasons was significantly greater than withdrawal from the low-BUN groups. Hospitalization was also greater in the high-BUN groups, but dialysis treatment time had no significant effects. The data indicate that the occurrence of morbid events is affected by the dialysis prescription. Increased morbidity appears to accompany prescriptions associated with a relatively high BUN. Conversely, morbidity may be decreased by prescriptions associated with more efficient removal of urea if the dietary intake of protein and other nutrients is adequate.
J Clin Endocrinol Metab, 1970
American Journal of Kidney Diseases, Jan 8, 2007
Transactions American Society For Artificial Internal Organs, Feb 1, 1969
Kidney International, 2010
Developments in Nephrology, 1998
Quality Assurance in Dialysis, 1994
These guidelines are based on the best information available at the time of publication. They are... more These guidelines are based on the best information available at the time of publication. They are designed to provide information and assist in decision making. They are not intended to define a standard of care, and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of these guidelines is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. K/DOQI is a trademark of the National Kidney Foundation. FOREWORD F ROM ITS RUDIMENTARY beginnings in the 1960s, renal replacement therapy has become a lifesaving treatment that can provide end-stage renal disease (ESRD) patients with a good quality of life. As a resu...
Reprocessing dialysers for multiple uses: recent analysis of death risks for patients
Computers and Biomedical Research, 1976
ABSTRACT
California Medicine, 1968
These discussions are selected from the weekly staff conferences in the Department of Medicine, U... more These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California Medical Center, San Francisco. Taken from transcriptions, they are prepared by Drs. Martin J. Cline and Hibbard E. Williams, Associate Professors of Medicine, under the direction of Dr. Lloyd H. Smith, Jr., Professor of Medicine and Chairman of the Department of Medicine.
Computers and Biomedical Research, 1976
ABSTRACT
Nephrology Dialysis Transplantation
Kidney International, 2009
N Engl J Med, 1981
This report summarizes morbidity in 151 patients in a cooperative trial designed to evaluate the ... more This report summarizes morbidity in 151 patients in a cooperative trial designed to evaluate the clinical effects of different dialysis prescriptions. Four treatment groups were divided along two dimensions: dialysis treatment time (long or short), and blood urea nitrogen (BUN) concentration averaged with respect to time (TACurea) (high or low). Dietary protein was not restricted. There was no difference in mortality between the groups. Withdrawal of patients from the high-BUN groups for medical reasons was significantly greater than withdrawal from the low-BUN groups. Hospitalization was also greater in the high-BUN groups, but dialysis treatment time had no significant effects. The data indicate that the occurrence of morbid events is affected by the dialysis prescription. Increased morbidity appears to accompany prescriptions associated with a relatively high BUN. Conversely, morbidity may be decreased by prescriptions associated with more efficient removal of urea if the dietary intake of protein and other nutrients is adequate.
J Clin Endocrinol Metab, 1970
American Journal of Kidney Diseases, Jan 8, 2007
Transactions American Society For Artificial Internal Organs, Feb 1, 1969
Kidney International, 2010
Developments in Nephrology, 1998
Quality Assurance in Dialysis, 1994